JP2022534429A5 - - Google Patents

Info

Publication number
JP2022534429A5
JP2022534429A5 JP2021570964A JP2021570964A JP2022534429A5 JP 2022534429 A5 JP2022534429 A5 JP 2022534429A5 JP 2021570964 A JP2021570964 A JP 2021570964A JP 2021570964 A JP2021570964 A JP 2021570964A JP 2022534429 A5 JP2022534429 A5 JP 2022534429A5
Authority
JP
Japan
Prior art keywords
crystalline polymorph
cyclohexa
isopropylthio
pyrazole
thiazole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021570964A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022534429A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/035343 external-priority patent/WO2020243584A1/en
Publication of JP2022534429A publication Critical patent/JP2022534429A/ja
Publication of JP2022534429A5 publication Critical patent/JP2022534429A5/ja
Priority to JP2025117422A priority Critical patent/JP2025160244A/ja
Pending legal-status Critical Current

Links

JP2021570964A 2019-05-31 2020-05-29 １－チアゾール－２－イル－ピラゾール－５－カルボン酸誘導体の結晶多形 Pending JP2022534429A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025117422A JP2025160244A (ja) 2019-05-31 2025-07-11 １－チアゾール－２－イル－ピラゾール－５－カルボン酸誘導体の結晶多形

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962855671P 2019-05-31 2019-05-31
US62/855,671 2019-05-31
PCT/US2020/035343 WO2020243584A1 (en) 2019-05-31 2020-05-29 Crystalline polymorphs of a 1-thiazol-2-yl-pyrazole-5-carboxylic acid derivative

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025117422A Division JP2025160244A (ja) 2019-05-31 2025-07-11 １－チアゾール－２－イル－ピラゾール－５－カルボン酸誘導体の結晶多形

Publications (2)

Publication Number Publication Date
JP2022534429A JP2022534429A (ja) 2022-07-29
JP2022534429A5 true JP2022534429A5 (https=) 2023-06-06

Family

ID=71787116

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021570964A Pending JP2022534429A (ja) 2019-05-31 2020-05-29 １－チアゾール－２－イル－ピラゾール－５－カルボン酸誘導体の結晶多形
JP2025117422A Pending JP2025160244A (ja) 2019-05-31 2025-07-11 １－チアゾール－２－イル－ピラゾール－５－カルボン酸誘導体の結晶多形

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025117422A Pending JP2025160244A (ja) 2019-05-31 2025-07-11 １－チアゾール－２－イル－ピラゾール－５－カルボン酸誘導体の結晶多形

Country Status (7)

Country Link
US (1) US12378234B2 (https=)
EP (1) EP3976606A1 (https=)
JP (2) JP2022534429A (https=)
CN (1) CN114901655A (https=)
AU (2) AU2020283129A1 (https=)
CA (1) CA3142196A1 (https=)
WO (1) WO2020243584A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3081983A1 (en) * 2016-11-30 2018-06-07 Bantam Pharmaceutical, Llc Substituted pyrazole compounds and methods of using them for treatment of hyperproliferative diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1248869A2 (en) * 2000-01-07 2002-10-16 Transform Pharmaceuticals, Inc. High-throughput formation, identification, and analysis of diverse solid-forms
US12150934B2 (en) 2016-11-30 2024-11-26 Bantam Pharmaceutical, Llc Methods of using substituted pyrazole and pyrazole compounds and for treatment of hyperproliferative diseases
CA3081983A1 (en) * 2016-11-30 2018-06-07 Bantam Pharmaceutical, Llc Substituted pyrazole compounds and methods of using them for treatment of hyperproliferative diseases

Similar Documents

Publication Publication Date Title
JP2007521340A5 (https=)
KR102564647B1 (ko) 3-((1R,3R)-1-(2,6-다이플루오로-4-((1-(3-플루오로프로필)아제티딘-3-일)아미노)페닐)-3-메틸-1,3,4,9-테트라하이드로-2H-피리도[3,4-b]인돌-2-일)-2,2-다이플루오로프로판-1-올의 고체 형태, 치환된 페닐 또는 피리딘일 잔기를 포함하는 융합된 삼환형 화합물의 제조 방법, 및 이의 사용 방법
CN109641844B (zh) 整合应激通路的调节剂
RU2012138892A (ru) СОЛИ И ПОЛИМОРФЫ 8-ФТОР-2-{4-[(МЕТИЛАМИНО)МЕТИЛ]ФЕНИЛ}-1,3,4,5,-ТЕТРАГИДРО-6Н-АЗЕПИНО[5,4,3-cd]ИНДОЛ-6-ОНА
ES2527768T5 (es) Sales cristalinas de sitagliptina
EP3842442A1 (en) Compositions and methods for inhibiting arginase activity
HRP20100166T1 (hr) Postupak za pripremu 2-aminotiazol-5-aromatičnih karboksamida kao inhibitora kinaze
HRP20120066T1 (hr) Kalijeva sol inhibitora hiv integraze
JP2019528276A5 (https=)
FI4209493T3 (fi) (s)-4-(8-amino-3-(1-(but-2-ynoyyli)pyrrolidin-2-yyli)imidatso[1,5-a]pyratsin-1-yyli)-n-(pyridin-2-yyli)bentsamidin kiinteitä muotoja ja formulaatioita
JP2023002516A5 (https=)
JP6553615B2 (ja) 疼痛に対して多重モードの活性を有するピペラジン誘導体
JP2024537795A5 (https=)
CA2875966A1 (en) Compounds and compositions for modulating egfr activity
JP2022532178A (ja) 置換フェニルプロペニルピリジン誘導体、その調製方法及びその医学的使用
JP5184511B2 (ja) 新しい結晶形態のラミブジン
RU2014145544A (ru) Солевая форма ингибитора гистон-метилтрансферазы ezh2 человека
RU2009115860A (ru) Фармацевтические композиции ингибиторов hdac и образующих хелатные комплексы соединений металла и хелатные комплексы ингибитора hdac с металлом
CN108366979B (zh) 与泛素化－蛋白酶体系统有关的化合物及医药组合物
JP2023529867A (ja) 線維芽細胞増殖因子受容体キナーゼの阻害剤
HRP20160044T1 (hr) Novi spojevi fenilamino izonikotinamida
SI3033344T1 (en) CHEMISULPHATE SOL 5,10-METHYLENE- (6R) -THETRAHYDROPHOLIC ACID
IL273974B2 (en) Amine-disubstituted heterocyclic compounds as ehmt2 inhibitors, salts thereof and method for their synthesis
WO2017194459A1 (de) Substituierte 5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-a]pyridin-3(2h)-one und 2,5,6,7-tetrahydro-3h-pyrrolo[2,1-c][1,2,4]triazol-3-one und ihre verwendung
JP2013514974A5 (https=)